On Sept. 9, 2020, the AAFP reviewed and agreed with the Advisory Committee on Immunization Practices’ recommendations for the 2020-2021 influenza season, which ﾗ among other things ﾗ call for all patients ages 6 months and older who have no contraindications to be appropriately immunized.

several inactivated influenza vaccines, a recombinant influenza vaccine and a live attenuated influenza vaccine. With one exception, these products will be quadrivalent; MF59-adjuvanted IIV is expected to be available in both quadrivalent and trivalent formulations.